Moreover, in IDH-wildtype diffuse astrocytic gliomas the presence of one or more of three genetic parameters (EGFR gene amplification, TERT promoter mutation, 7+/10−) appears to be adequate to assign the highest CNS WHO grade and classify them as glioblastoma-wildtype. The gene discussed is IDH1; the disease is glioblastoma.